Form 4: Teradyne Director Sells Shares Under 10b5-1 Plan

Teradyne Director Mercedes Johnson sold 625 shares of common stock for $299.2 per share under a pre-arranged 10b5-1 trading plan.

Summary

• Mercedes Johnson, a Director of Teradyne, Inc., sold 625 shares of the company's common stock.
• The transaction occurred on March 5, 2026, at a price of $299.2 per share.
• The sale was executed under a Rule 10b5-1 trading plan adopted on February 3, 2025.
• Following the sale, Mercedes Johnson directly owns 6,988 shares and indirectly owns 1,876 shares through a trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. While an insider sale can sometimes be perceived negatively, the execution under a pre-arranged 10b5-1 plan mitigates concerns that it's based on new, adverse information.

Negatives

• A director sold 625 shares of common stock, which could be perceived as a slight negative signal, though mitigated by the pre-arranged 10b5-1 plan.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider sales, even when pre-planned under Rule 10b5-1, are routinely monitored by investors for potential insights into management's perception of future company performance or personal liquidity needs. The sale by a director of a semiconductor test equipment company like Teradyne is a routine event, but the specific timing and volume are always scrutinized.

Related Party Transactions

• 1,876 shares are held indirectly by The Mercedes Johnson Trust UAD 07/23/04, of which the Reporting Person is the trustee and sole beneficiary.

Stakeholder Impact

• Shareholders: The sale by a director, even if pre-planned, might lead to minor speculation among shareholders regarding the director's confidence in the company, though the 10b5-1 plan typically reduces this concern.

Key Dates

Recommendation

The transaction is a routine insider sale executed under a pre-arranged 10b5-1 plan, which typically indicates personal financial planning rather than a change in the director's outlook on the company's fundamentals. It does not provide new information that would warrant a change in investment recommendation.

Keywords

Teradyne, TER, Form 4, Insider Trading, Stock Sale, Director, Mercedes Johnson, 10b5-1 Plan, Equity Transaction